St. Baldrick’s carnival event, head shaving fundraiser for cancer

St. Baldrick’s carnival event, head shaving fundraiser for cancer

TROY, N.Y. (NEWS10) — The Hudson Valley Community College Nursing Club sponsored a carnival-themed St. Baldrick’s event for cancer research. Until 4 p.m. on Saturday, they’re trying to raise five figures or more for pediatric cancer.

Get the latest news, weather, sports and more delivered right to your inbox!Besides the carnival theme, students, faculty, and community members are shaving their heads for lifesaving childhood cancer research at the Saint Baldrick’s Foundation event on HVCC Campus. Anyone was welcome to sign up to become a “shavee.”

With a goal of raising $10,000, the event takes place at the student pavilion. They’ll be accepting walk-ins appointments, too.

Source: St. Baldrick’s carnival event, head shaving fundraiser for cancer

For 80% of childhood cancer survivors, serious health risks follow: study

For 80% of childhood cancer survivors, serious health risks follow: study

By age 45, more than 80 per cent of childhood cancer survivors will grapple with serious or life-threatening effects stemming from their treatments. These repercussions range from heart disease to colorectal and breast cancer, according to a recent Canadian study.

The study, published Monday in the Canadian Medical Association Journal (CMAJ), found that adult survivors of childhood cancer are at elevated risk of sickness and death compared to the general population.

The risk of colorectal cancer is two to three times higher than for the general population. Additionally, females who received chest radiation therapy during childhood have a breast cancer risk similar to individuals with a genetic mutation predisposing them to the disease.

“I think people believe that you treat a child with cancer, you cure them, and then it’s fantastic and that we move on,” said Dr. Paul Nathan, co-author of the study and an oncologist in the division of haematology and oncology at SickKids in Toronto.

Source: For 80% of childhood cancer survivors, serious health risks follow: study

Pediatric cancer survivor becomes nurse, works with LVHN nurse who cared for her

Pediatric cancer survivor becomes nurse, works with LVHN nurse who cared for her

A Lehigh Valley nurse and her former patient are back together again, but this time, they are both taking care of those who need them.

It’s a full circle moment at Lehigh Valley Health Network.

Olivia Radcliffe was just 10 years old when she was diagnosed with a rare liver cancer. She’s 22 now, cancer-free and giving back in such a big way.

Source: Pediatric cancer survivor becomes nurse, works with LVHN nurse who cared for her

Targeting specific protein regions offers a new treatment approach in medulloblastoma

Targeting specific protein regions offers a new treatment approach in medulloblastoma

(MEMPHIS, Tenn. – April 25, 2024) Medulloblastoma (the most common malignant childhood brain tumor) is separated into four molecular groups, with Group 3 bearing the worst prognosis. By studying EP300 and CBP, critical proteins in Group 3 medulloblastoma cells, scientists at St. Jude Children’s Research Hospital designed a way to enhance anti-tumor activity by targeting a specific part of these proteins. This targeted approach significantly reduced cancer cell growth. The findings were reported today in Nature Communications.

Previous research by St. Jude scientists and others has classified medulloblastoma into four distinct molecular groups: WNT and SHH — driven by their namesake genetic mutations — Group 3 and Group 4. The prognosis for medulloblastoma is different for each molecular group. Retrospective analyses have shown that WNT tumors have 95% five-year survival. SHH and Group 4 tumors have approximately 75% five-year survival, and the survival rate for Group 3 is only 60%. Approximately one-third of all patients with medulloblastoma relapse, but the rate of relapse varies based on factors such as the patient’s age and what type of therapy they receive.

Source: Targeting specific protein regions offers a new treatment approach in medulloblastoma

Forbes|SHOOK Top Advisors Donate $1.5M For Life-Saving Pediatric Cancer Treatment

Forbes|SHOOK Top Advisors Donate $1.5M For Life-Saving Pediatric Cancer Treatment

Top Advisors at the Forbes|SHOOK Top Advisor Summit in Las Vegas donated $1.5 million to fund a potentially lifesaving treatment for kids with one of the deadliest forms of cancer: relapsed high-risk neuroblastoma. Kids with relapsed high-risk neuroblastoma face a less than 5% chance of survival. The sold-out event occurs every October.

The Children’s Cancer Research Fund effort will help break the limits of current immunotherapies, making it safer and more effective for kids. It will also lay the groundwork for scientists to use the therapy for additional childhood cancers.

Source: Forbes|SHOOK Top Advisors Donate $1.5M For Life-Saving Pediatric Cancer Treatment